GlassScriptPhysician profile
Monica Verma
NPI 1518948124
$9,538.09
in general payments reported to CMS, 2019-2025
62 companies · $849 in 2025
The $849 reported for 2025 was more than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,363 · 2020: $994 · 2021: $1,492 · 2022: $1,300 · 2023: $796 · 2024: $744 · 2025: $849.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,371 · Education: $17.02.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,371.36 |
| Education | $17.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,856.15 | 2019-2022 | |
| Pfizer INC. | $753.96 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $520.48 | 2019-2025 | Keytruda |
| Astrazeneca Pharmaceuticals LP | $501.37 | 2019-2025 | Imfinzi, Lynparza, Calquence |
| Seagen INC. | $425.96 | 2019-2023 | Adcetris |
| E.R. Squibb & Sons, L.L.C. | $370.15 | 2019-2025 | Opdivo |
| Novartis Pharmaceuticals Corporation | $370.01 | 2019-2025 | |
| Genentech USA, INC. | $322.94 | 2019-2025 | Phesgo, Perjeta, Polivy |
| Bayer Healthcare Pharmaceuticals INC. | $273.70 | 2019-2025 | |
| Novocure Gmbh | $250.00 | 2022 | |
| Amgen INC. | $247.77 | 2019-2023 | Kyprolis, Blincyto |
| Glaxosmithkline, LLC. | $220.97 | 2019-2025 | Ojjaara, Jemperli, Zejula |
| Daiichi Sankyo INC. | $220.30 | 2019-2025 | Enhertu, Datroway |
| Gilead Sciences, INC. | $212.23 | 2021-2025 | Trodelvy |
| Eisai INC. | $182.34 | 2020-2025 |
Show all 62 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monica Verma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.